The generic drug market still faces structural and purchasing hurdles despite strong U.S. growth, an industry group noted on Wednesday, after President Donald Trump said imported generic medicines would face up to 200% tariffs after two years.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
